Article contents
Development and implementation of a short duration antibiotic therapy algorithm for uncomplicated gram-negative bloodstream infections
Published online by Cambridge University Press: 04 May 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Aarticle%3AS0899823X21001665/resource/name/firstPage-S0899823X21001665a.jpg)
- Type
- Research Brief
- Information
- Copyright
- © The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Footnotes
PREVIOUS PRESENTATION. These data were presented as a poster at IDWeek 2020 on October 22, 2020, conducted virtually.
References
Yahav, D, Franceschini, E, Koppel, F, et al. Seven versus 14 days of antibiotic therapy for uncomplicated gram-negative bacteremia: a noninferiority randomized controlled trial. Clin Infect Dis 2019;69:1091–1098.CrossRefGoogle ScholarPubMed
Chotiprasitsakul, D, Han, JH, Cosgrove, SE, et al. Comparing the outcomes of adults with enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort. Clin Infect Dis 2018;66:172–177.CrossRefGoogle Scholar
Von dach, E, Albrich, WC, Brunel, AS, et al. Effect of C-reactive protein-guided antibiotic treatment duration, 7-day treatment, or 14-day treatment on 30-day clinical failure rate in patients with uncomplicated gram-negative bacteremia: a randomized clinical trial. JAMA 2020;323:2160–2169.CrossRefGoogle ScholarPubMed
Corey, GR, Stryjewski, ME, Everts, RJ. Short-course therapy for bloodstream infections in immunocompetent adults. Int J Antimicrob Agents 2009;34 suppl 4:S47–S51.CrossRefGoogle Scholar
Swamy, S, Sharma, R. Duration of treatment of gram-negative bacteremia: are shorter courses of antimicrobial therapy feasible? Infect Dis Clin Pract 2016;24:155–160.CrossRefGoogle Scholar
- 2
- Cited by